Report cover image

Diabetic Foot Ulcer Treatment Market

Publisher Transparency Market Research Pvt. Ltd.
Published Jul 17, 2023
Length 183 Pages
SKU # TNPR18164150

Description

Diabetic Foot Ulcer Treatment Market (Treatment Type: Wound Care Dressing, Wound Care Devices, Active Therapies, Antibiotic Medications, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Diabetic Foot Ulcer Treatment Market – Scope of Report

TMR’s report on the global diabetic foot ulcer treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global diabetic foot ulcer treatment market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global diabetic foot ulcer treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the diabetic foot ulcer treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global diabetic foot ulcer treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global diabetic foot ulcer treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global diabetic foot ulcer treatment market.

The report delves into the competitive landscape of the global diabetic foot ulcer treatment market. Key players operating in the global diabetic foot ulcer treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global diabetic foot ulcer treatment market profiled in this report.

Key Questions Answered in Global Diabetic Foot Ulcer Treatment Market Report
  • What is the sales/revenue generated by diabetic foot ulcer treatment across all regions during the forecast period?
  • What are the opportunities in the global diabetic foot ulcer treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Diabetic Foot Ulcer Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global diabetic foot ulcer treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global diabetic foot ulcer treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global diabetic foot ulcer treatment market.

Table of Contents

183 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diabetic Foot Ulcer Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Diabetic Foot Ulcer Prevalence: Overview
5.3. Application of 3D Printing in Treatment of Diabetic Foot Ulcer: Overview
5.4. Technological Advancement in Diabetic Foot Ulcer Management: Overview
5.5. Awareness Programs Assessment
6. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2017-2031
6.3.1. Wound Care Dressing
6.3.1.1. Antimicrobial Dressing
6.3.1.2. Foam Dressing
6.3.1.3. Film Dressing
6.3.1.4. Alginate Dressing
6.3.1.5. Hydrogel Dressing
6.3.1.6. Others
6.3.2. Wound Care Devices
6.3.2.1. Electromagnetic Devices
6.3.2.2. Negative Pressure Wound Therapy (NPWT)
6.3.2.3. Ultra Sound Therapy
6.3.2.4. Hyperbaric Oxygen Therapy (HBOT)
6.3.3. Active Therapies
6.3.3.1. Skin Grafts & Substitutes
6.3.3.2. Growth Factors
6.3.3.3. Hemostatic Agents & Sealants
6.3.4. Antibiotic Medications
6.3.5. Others
6.3.5.1. Pressure Relief Devices
6.3.5.2. Traditional Wound Care Products
6.3.5.3. Others
6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by Grade of Ulcer
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
7.3.1. Grade 1
7.3.2. Grade 2
7.3.3. Grade 3
7.3.4. Grade 4
7.3.5. Grade 5
7.4. Market Attractiveness Analysis, by Grade of Ulcer
8. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by Ulcer Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Ulcer Type, 2017-2031
8.3.1. Neuropathic Ulcers
8.3.2. Ischemic Ulcers
8.3.3. Neuro-Ischemic Ulcers
8.4. Market Attractiveness Analysis, by Ulcer Type
9. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.3.4. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Diabetic Foot Ulcer Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment Type, 2017-2031
11.2.1. Wound Care Dressing
11.2.1.1. Antimicrobial Dressing
11.2.1.2. Foam Dressing
11.2.1.3. Film Dressing
11.2.1.4. Alginate Dressing
11.2.1.5. Hydrogel Dressing
11.2.1.6. Others
11.2.2. Wound Care Devices
11.2.2.1. Electromagnetic Devices
11.2.2.2. Negative Pressure Wound Therapy (NPWT)
11.2.2.3. Ultra Sound Therapy
11.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
11.2.3. Active Therapies
11.2.3.1. Skin Grafts & Substitutes
11.2.3.2. Growth Factors
11.2.3.3. Hemostatic Agents & Sealants
11.2.4. Antibiotic Medications
11.2.5. Others
11.2.5.1. Pressure Relief Devices
11.2.5.2. Traditional Wound Care Products
11.2.5.3. Others
11.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
11.3.1. Grade 1
11.3.2. Grade 2
11.3.3. Grade 3
11.3.4. Grade 4
11.3.5. Grade 5
11.4. Market Value Forecast, by Ulcer Type, 2017-2031
11.4.1. Neuropathic Ulcers
11.4.2. Ischemic Ulcers
11.4.3. Neuro-Ischemic Ulcers
11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Specialty Clinics
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Treatment Type
11.7.2. By Grade of Ulcer
11.7.3. By Ulcer Type
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe Diabetic Foot Ulcer Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment Type, 2017-2031
12.2.1. Wound Care Dressing
12.2.1.1. Antimicrobial Dressing
12.2.1.2. Foam Dressing
12.2.1.3. Film Dressing
12.2.1.4. Alginate Dressing
12.2.1.5. Hydrogel Dressing
12.2.1.6. Others
12.2.2. Wound Care Devices
12.2.2.1. Electromagnetic Devices
12.2.2.2. Negative Pressure Wound Therapy (NPWT)
12.2.2.3. Ultra Sound Therapy
12.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
12.2.3. Active Therapies
12.2.3.1. Skin Grafts & Substitutes
12.2.3.2. Growth Factors
12.2.3.3. Hemostatic Agents & Sealants
12.2.4. Antibiotic Medications
12.2.5. Others
12.2.5.1. Pressure Relief Devices
12.2.5.2. Traditional Wound Care Products
12.2.5.3. Others
12.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
12.3.1. Grade 1
12.3.2. Grade 2
12.3.3. Grade 3
12.3.4. Grade 4
12.3.5. Grade 5
12.4. Market Value Forecast, by Ulcer Type, 2017-2031
12.4.1. Neuropathic Ulcers
12.4.2. Ischemic Ulcers
12.4.3. Neuro-Ischemic Ulcers
12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Specialty Clinics
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Treatment Type
12.7.2. By Grade of Ulcer
12.7.3. By Ulcer Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Diabetic Foot Ulcer Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment Type, 2017-2031
13.2.1. Wound Care Dressing
13.2.1.1. Antimicrobial Dressing
13.2.1.2. Foam Dressing
13.2.1.3. Film Dressing
13.2.1.4. Alginate Dressing
13.2.1.5. Hydrogel Dressing
13.2.1.6. Others
13.2.2. Wound Care Devices
13.2.2.1. Electromagnetic Devices
13.2.2.2. Negative Pressure Wound Therapy (NPWT)
13.2.2.3. Ultra Sound Therapy
13.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
13.2.3. Active Therapies
13.2.3.1. Skin Grafts & Substitutes
13.2.3.2. Growth Factors
13.2.3.3. Hemostatic Agents & Sealants
13.2.4. Antibiotic Medications
13.2.5. Others
13.2.5.1. Pressure Relief Devices
13.2.5.2. Traditional Wound Care Products
13.2.5.3. Others
13.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
13.3.1. Grade 1
13.3.2. Grade 2
13.3.3. Grade 3
13.3.4. Grade 4
13.3.5. Grade 5
13.4. Market Value Forecast, by Ulcer Type, 2017-2031
13.4.1. Neuropathic Ulcers
13.4.2. Ischemic Ulcers
13.4.3. Neuro-Ischemic Ulcers
13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Specialty Clinics
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Treatment Type
13.7.2. By Grade of Ulcer
13.7.3. By Ulcer Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Diabetic Foot Ulcer Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Treatment Type, 2017-2031
14.2.1. Wound Care Dressing
14.2.1.1. Antimicrobial Dressing
14.2.1.2. Foam Dressing
14.2.1.3. Film Dressing
14.2.1.4. Alginate Dressing
14.2.1.5. Hydrogel Dressing
14.2.1.6. Others
14.2.2. Wound Care Devices
14.2.2.1. Electromagnetic Devices
14.2.2.2. Negative Pressure Wound Therapy (NPWT)
14.2.2.3. Ultra Sound Therapy
14.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
14.2.3. Active Therapies
14.2.3.1. Skin Grafts & Substitutes
14.2.3.2. Growth Factors
14.2.3.3. Hemostatic Agents & Sealants
14.2.4. Antibiotic Medications
14.2.5. Others
14.2.5.1. Pressure Relief Devices
14.2.5.2. Traditional Wound Care Products
14.2.5.3. Others
14.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
14.3.1. Grade 1
14.3.2. Grade 2
14.3.3. Grade 3
14.3.4. Grade 4
14.3.5. Grade 5
14.4. Market Value Forecast, by Ulcer Type, 2017-2031
14.4.1. Neuropathic Ulcers
14.4.2. Ischemic Ulcers
14.4.3. Neuro-Ischemic Ulcers
14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Specialty Clinics
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Treatment Type
14.7.2. By Grade of Ulcer
14.7.3. By Ulcer Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Diabetic Foot Ulcer Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Treatment Type, 2017-2031
15.2.1. Wound Care Dressing
15.2.1.1. Antimicrobial Dressing
15.2.1.2. Foam Dressing
15.2.1.3. Film Dressing
15.2.1.4. Alginate Dressing
15.2.1.5. Hydrogel Dressing
15.2.1.6. Others
15.2.2. Wound Care Devices
15.2.2.1. Electromagnetic Devices
15.2.2.2. Negative Pressure Wound Therapy (NPWT)
15.2.2.3. Ultra Sound Therapy
15.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
15.2.3. Active Therapies
15.2.3.1. Skin Grafts & Substitutes
15.2.3.2. Growth Factors
15.2.3.3. Hemostatic Agents & Sealants
15.2.4. Antibiotic Medications
15.2.5. Others
15.2.5.1. Pressure Relief Devices
15.2.5.2. Traditional Wound Care Products
15.2.5.3. Others
15.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
15.3.1. Grade 1
15.3.2. Grade 2
15.3.3. Grade 3
15.3.4. Grade 4
15.3.5. Grade 5
15.4. Market Value Forecast, by Ulcer Type, 2017-2031
15.4.1. Neuropathic Ulcers
15.4.2. Ischemic Ulcers
15.4.3. Neuro-Ischemic Ulcers
15.5. Market Value Forecast, by End-user, 2017-2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.5.4. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Treatment Type
15.7.2. By Grade of Ulcer
15.7.3. By Ulcer Type
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Convatec, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Acelity L.P., Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. 3M Health Care
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Coloplast Corp.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Smith & Nephew Plc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. B Braun Melsungen AG
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Medline Industries, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Organogenesis, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Mölnlycke Health Care
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. PAUL HARTMANN AG
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Centaur Pharmaceuticals
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. GlaxoSmithKline
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. Pfizer
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. Dr. Reddy’s Laboratories
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us